Skip to main content

Table 2 categorization of patients and average values of gemcitabine efficacy.

From: Modelling non-homogeneous stochastic reaction-diffusion systems: the case study of gemcitabine-treated non-small cell lung cancer growth

Category of patient

Median value of efficacy

Male

0.03817219 (cm · hours)-1

Female

0.03815441 (cm · hours)-1

Smoker

0.02937583 (cm · hours)-1

Ex-smoker

0.07753538 (cm · hours)-1

Non-Smoker

0.03815441 (cm · hours)-1

Back to article page